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Background: We report on a 6-year-old Turkish boy with profound sensorineural deafness, balance disorder, severe
disorder of oral motor function, and mild developmental delay. Further findings included scaphocephaly,
plagiocephaly, long palpebral fissures, high narrow palate, low-set posteriorly rotated ears, torticollis, hypoplastic
genitalia and faulty foot posture. Parents were consanguineous.
Methods and results: Computed tomography and magnetic resonance imaging showed bilateral single widened
cochlear turn, narrowing of the internal auditory canal, and bilateral truncation of the vestibulo-cochlear nerve.
Microarray analysis and next generation sequencing showed a homozygous deletion of chromosome 5q31.1
spanning 115.3 kb and including three genes: NEUROG1 (encoding neurogenin 1), DCNP1 (dendritic cell nuclear
protein 1, C5ORF20) and TIFAB (TIFA-related protein). The inability to chew and swallow, deafness and balance
disorder represented congenital palsies of cranial nerves V (trigeminal nerve) and VIII (vestibulo-cochlear nerve) and
thus a congenital cranial dysinnervation disorder.
Conclusions: Based on reported phenotypes of neurog1 null mutant mice and other vertebrates, we strongly
propose NEUROG1 as the causative gene in this boy. The human NEUROG1 resides within the DFNB60 locus for
non-syndromic autosomal recessive deafness on chromosome 5q22-q31, but linkage data have excluded it from
being causative in the DFNB60 patients. Given its large size (35 Mb, >100 genes), the 5q22-q31 area could harbor
more than one deafness gene. We propose NEUROG1 as a new gene for syndromic autosomal recessive hearing
loss and congenital cranial dysinnervation disorder including cranial nerves V and VIII.
Keywords: Congenital cranial dysinnervation disorder, Moebius syndrome variant, Mondini dysplasia, Sensorineural
deafness, Disorder of oral motor function, Aplasia/hypoplasia of cranial sensory ganglia, Aplasia/hypoplasia of cranial
nerves V and VIII, NEUROG1, Homozygous deletion, Autosomal recessive* Correspondence: julia.cornelia.schroeder@gmx.net
1Institute of Human Genetics, University Medical Centre of the Johannes
Gutenberg University Mainz, Langenbeckstrasse 1, D-55101, Mainz, Germany
Full list of author information is available at the end of the article
© 2013 Schröeder et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Schröder et al. Behavioral and Brain Functions 2013, 9:7 Page 2 of 7
http://www.behavioralandbrainfunctions.com/content/9/1/7Background
The term congenital cranial dysinnervation disorder (CCDD)
describes a heterogeneous group of neurodevelopmental
diseases affecting the cranial nerves and its nuclei [1]. At
present, a total of 10 phenotypes fall under the CCDD um-
brella, including congenital ptosis, Duane syndrome, hori-
zontal gaze palsy, and congenital facial palsy [2]. Some
authors also include Moebius syndrome, which is defined by
affection of cranial nerves VI and VII, and the Moebius syn-
drome variants (predominant affection of cranial nerves
other than VI and VII) in the entity of CCDD [1,2]. In
CCDD, seven disease genes have been identified to date, but
a number of additional loci and phenotypes still await gene
elucidation [2]. Current evidence supports the concept that
the CCDDs are primarily due to neurogenic disturbances of
brainstem or cranial nerve development [2].
The cranial sensory ganglia can be separated into two
groups according to the origin of their constituent
neurons. The proximal ganglia originate from the
trigeminal and otic placodes and the neural crest,
whereas the distal ganglia are derived from the other
epibranchial placodes (facial, glossopharyngeal and vagus
placode) [3]. Hence, the proximal ganglia include the
ganglia for cranial nerves V, VIII and XI (trigeminal,
vestibulo-cochlear and accessory nerves). The distal gan-
glia include the geniculate ganglion for cranial nerve VII,
and cranial nerves IX and X are formed by both prox-
imal (IXth and Xth, superior-jugular) and distal (IXth,
petrosal and Xth, nodose) ganglia [4]. Cranial nerve V
(trigeminal nerve) includes motoric nerve fibers in
addition to sensory ones; these are derived from the nu-
cleus motorius nervi trigemini in the rhombencephalon.
Cranial nerve VI (abducens nerve) does not contain sen-
sory nerve fibers. Neuronal development of all cranial
sensory ganglia requires different basic helix-loop-helix
transcription factors [5], including neurogenin1 (neurog1)
and neurogenin2 (neurog2) [6]. Altered expression of
neuronal differentiation helix-loop-helix transcription fac-
tor genes deranges neuronal differentiation in the central
and the peripheral nervous system [5]. Studies in null mu-
tant mice for neurog1 and neurog2 revealed a developmen-
tal halt of neurogenesis in cranial sensory ganglia at
earliest stages [7]. Neurog1 was essential for the formation
of the proximal cranial sensory neurons and neurog2 was
found to be more involved in control of the distal cranial
sensory neurons [8-10].
Clinical findings in CCDDs can include hearing loss
and anatomic deviations of the cochlea and the vestibu-
lar apparatus [1]. Disturbances in embryogenesis of the
otic placode can lead to sensorineural hearing loss and
cochlear malformation. A common malformation of the
cochlea is Mondini dysplasia, which is characterized by a
cochlea of only 1.5 turns instead of the normal 2.5 turns.
The interscalar septum between the middle and theapical coil is absent, leading to a common apical cham-
ber with cystic dilatation. The vestibular system is
affected in some cases [11]. Sensorineural hearing loss
can also be caused by developmental disorders of the
cranial sensory ganglia and the vestibulo-cochlear nerve.
Here we report on a 6-year-old boy with consanguin-
eous parents displaying numerous clinical features, in-
cluding profound sensorineural hearing loss, bilateral
aplasia of cranial nerve VIII, cochlear hypoplasia (incom-
plete Mondini dysplasia), a severe disorder of oral motor
function and torticollis. Genomic analysis identified a
homozygous 5q31.1 deletion spanning 115 kb and in-
cluding the Neurogenin1 gene (NEUROG1). The con-
genital palsy of cranial nerves V (causing the severe gulp
and mouth motor disorder) and VIII (causing the
deafness) represents a congenital cranial dysinnervation
disorder or Moebius syndrome variant and we suggest
NEUROG1 as the likely causative gene in this boy.
Methods
This research was performed with the approval of the
Ethics Board of the University Medical Center Mainz
and in compliance with the Helsinki Declaration.
Clinical report
The 6-year-old proband was the first child of healthy
consanguineous Turkish parents. His parents were sec-
ond cousins. The parents reported that their common
grandfather developed hearing impairment before age
50 years and that a great-granddaughter of their grand-
father´s sister had received cochlea implants due to con-
genital deafness. Further data were not available. The
proband was born by vacuum extraction after an un-
eventful pregnancy of 40 weeks gestation. The birth
weight was 3,750 g (50th to 75th percentile), length
52 cm (50th percentile), head circumference 35 cm
(50th percentile) and Apgar scores were 8 and 9 at 1
and 5 minutes. After birth, he was ventilated for one day
and treated with antibiotics due to suspected neonatal
sepsis. At age 4 months, he was hospitalized because of
episodes of screaming followed by sudden tonus loss. Global
developmental delay, muscular hypotonia and torticollis were
noticed. A metabolic disease was suspected but no diagnosis
was made. A brainstem evoked response audiometry (BERA)
test at age 8 months indicated profound bilateral deafness.
Cranial computed tomography imaging showed bilateral
stenosis of the internal auditory canal with a maximum
diameter of 1.1 mm and a hypoplastic cochlea with only a
single widened cochlear turn (Figure 1). Magnetic resonance
imaging confirmed the abnormalities and Mondini malfor-
mation was diagnosed. The vestibulocochlear nerve was
assumed to be aplastic because no nerval structure reaching
the cochlea could be identified. At age 8 months the boy was
fitted with hearing aids and at age 12 months with a cochlear
Figure 1 High resolution CT of the left petrosus bone. The
coronal view demonstrates the widened single basal cochlear turn
(black arrow) and the narrowing of the auditory canal (white arrow).
The patient did not show an enlarged vestibular aqueduct (EVA) but
similar findings of the right petrosus bone.
Schröder et al. Behavioral and Brain Functions 2013, 9:7 Page 3 of 7
http://www.behavioralandbrainfunctions.com/content/9/1/7implant (CI) on the left, but without any improvement in
hearing or speech acquisition. At age 2 ½ years he began to
walk freely. At age 4 years, he was fitted with a cochlear im-
plant on the right, but again without improving hearing or
speech.
When last seen at age 5 11/12 years, his length was
110 cm (5th percentile), weight was 21 kg (50th percent-
ile) and head circumference 53 cm (75th percentile). He
had plagioscaphocephaly, low-set posteriorly rotated
ears, high arched eyebrows, elongated palpebral fissures,
high and very narrow palate, funnel chest, sacral dimple,
and hypoplastic genitalia. He wore ortheses because ofFigure 2 The proband at age 3 ½ years. Note (A) hypotonic appearance
eyebrows, elongated palpebral fissures and low-set posteriorly rotated earsfaulty foot posture. His mother reported that he could
ride a tricycle, but not a bicycle. He could stand on one
leg only for a few seconds and an equilibrium disorder
was assumed (Figure 2). Neurological findings included
muscular hypotonia, increased salivation and a severe
gulp and mouth motor disorder. He could not chew and
needed mashed food. Intelligence testing showed large
variations in results: his IQ was 70 using the SON-R
(Snijders-Oomen non-verbal intelligence test) but 92
using the CPM-Raven (Raven´s Coloured Progressive
Matrices), indicating normal abilities to think clearly and
make sense of complexity (eductive ability), plus normal
abilities to store and reproduce information (reproduct-
ive ability).
At age 1 year, karyotyping and mutation analysis of the
GJB2 and GJB6 genes were performed with normal
results. At age 3 years, a subtelomere screen using
multiplex ligation-dependent probe amplification (MLPA)
yielded normal results. Genome-wide microarray and
NGS analyses were performed on samples taken at age 5
11/12 years.Genome-wide microarray analysis
The proband was among >200 patients studied by us
using genome-wide microarray analysis. The Affymetrix
Genome-Wide Human SNP Array 6.0 (~1,850,000
probes, 1.7 kb average distance between neighbouring
probes) was used with the GeneChip Genome-Wide
SNP Assay Kit 6.0 (Affymetrix, Santa Clara, CA). Data
were analysed with the Genotyping Console 4.0 software
(Affymetrix). Detection of CNVs required at least 5 con-
secutive abnormal probes spanning at least 100 kb in
length. Results were verified using quantitative real-time
PCR (qPCR)., balance disorder and torticollis, (B, C) scaphocephaly, high arched
, and (D) orthopedic aids for correction of faulty foot posture.
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generation sequencing
Using one flow cell lane of an Illumina HiSeq 2000, we
generated 115,420,519 50 nt single end reads, with
101,701,184 reads passing standard quality filters. Reads
were aligned to the human reference genome (GRCh37/
hg19) using the Bowtie algorithm (version 0.12.7) [12].
7,417,427 (7%) of the reads failed to align and 17,125,015
(17%) aligned to multiple locations and were removed,
leaving 77,455,596 (76%) unambiguously aligned reads.
After sorting reads based on genomic position using
the samtools software package [13], breakpoints were
determined using a statistical approach implemented in
the R programming language. Based on the existing gen-
etic and microarray data, we expected a homozygous dele-
tion and thus expected no sequence reads to align to the
deleted region. Away from the suspected deletion and out-
side of centromeres, we determined the distribution of a
genomic position to the closest sequence read. Using this
distribution, we determined the likelihood that a given
position was in a homozygously deleted locus: a genomic
position far from the closest sequencing read is more
likely to be in a deleted locus. For a given position, the
assigned p-value represents the fraction of all genomic
positions that are an equal or greater distance from the
closest read. The region identified by the Affymetrix SNP
6.0 GeneChip and the FREEC algorithm was examined in
detail, including the aligned reads and the resultant p-
values (Figure 3A, B) and identified a region where no
reads aligned.Figure 3 Definition of the homozygous deletion by NGS and breakpo
(black bars) and RefSeq genes (blue). (B) A plot showing a p-value represen
deletion. (C) The sequence at the start and stop of the homozygous deletiThe precise deletion sequence locus was determined
using PCR with primers designed based on the
NGS results, GCTTTTTCTCCTAAATTCTCTGG (for-
ward) and TCAGCCATCTTTGTTGTTTCC (reverse)
(Figure 3C). PCR was performed according to standard
protocols. The reaction mixture consisted of 2.5 μl 10x
PCR buffer, 2.5 μl 50 mM MgCl2, 2.5 μl 10 mM dNTP
mix, 1.0 μl (100 ng) of each forward and reverse primer,
0.5 μl (2.5 U) Taq polymerase, 14 μl PCR-grade water
und 100 ng template DNA. PCR amplification was
carried out with an initial denaturation step at 94C for
3 min, 35 cycles of 94C for 30 sec, primer-specific
annealing temperature of 55C for 30 sec, 72C for
60 sec and a final extension step at 72C for 10 min.
Following Exo/SAP digestion, PCR products were
sequenced using the CEQ DTCS Quick Start Kit
(Beckman Coulter, Krefeld, Germany) and separated on
a Beckman Coulter CEQ 8000 Genetic Analysis System.




Results of microarray analysis
Microarray analysis showed a homozygous deletion arr
5q31.1(134,764,990–134,875,777)x0 (GRCh37/hg19, ISC
N2009) in the patient and identical but heterozygous
deletions in the parents (Figure 4). The deletions were
confirmed using qPCR. The proximal breakpoint on
chromosome 5q31.1 was identified between 134,764,553int-spanning PCR analysis. (A) The locus, showing aligned reads
ting the likelihood that a genomic position is not in a homozygous
on; the black bars represent the location of primer sequences.
Figure 4 Results of microarray analysis in the patient. The homozygous deletion of chromosome 5q31.1 spans from 110.787 kb to
116.796 kb and includes three genes, C5ORF20 (DCNP1), TIFAB and NEUROG1. Both parents carried the same chromosomal microdeletion in
heterozygous state.
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134,875,777 and 134,881,349 bp (GRCh37/hg19), indi-
cating a deletion size between 110,787 bp (minimum
size) and 116,796 bp (maximum size) by microarray ana-
lysis (6,009 bp uncertainty).
Results of the molecular breakpoint mapping using NGS
and PCR analysis
Based on the NGS data for chromosome 5 (Figure 3), the
proximal and distal breakpoint on 5q31 mapped between
134,764,588 and 134,764,722 bp (GRCh37/hg19) and
134,879,972 and 134,880,106 bp (p ≤ 0.05), respectively,
indicating a deletion sized between 114,922 bp and
115,518 bp (269 bp uncertainty). By use of a breakpoint
spanning PCR, we then mapped the precise breakpoints to
134,764,601 bp (last preserved base, proximal breakpoint)
and 134,879,936 bp (first preserved base, distal breakpoint),
indicating a deletion size of (exactly) 115,334 kb. The
finding matched well with the approximate deletion interval
established by microarray analysis and confirmed that the
deletion interval comprised three genes, NEUROG1, TIFAB
and DCNP1, encompassing all exons and likely the
corresponding promotor regions (Figure 4).
Discussion
We described a boy with cochlear hypoplasia, multiple
neurogenetic abnormalities (profound sensorineural
hearing loss, balance disorder, disorder of oral motor
function, torticollis, and mild developmental delay) and
a homozygous deletion of chromosome 5q31.1 spanning
115,334 kb. The deletion predicted a nullisomy (homo-
zygous loss) for the Neurogenin1 gene (NEUROG1, alsocalled Neurogenic differentiation factor 3) and two other
genes, DCNP1 and TIFAB. To our knowledge, there has
been no previous report of a homozygous deletion in-
cluding these genes. In humans, none of these genes
(NEUROG1, DCNP1, TIFAB) was previously associated
with the clinical signs observed in this patient, but
findings in Xenopus and mice make NEUROG1 an ex-
cellent candidate gene [14].
The neurog1 and neurog2 genes and corresponding
proteins have been well studied in vertebrates. In Xen-
opus, neurog1 was shown to be essential for the expres-
sion of a cascade of downstream proteins that induce
neuronal differentiation. Overexpression of neurog1
induced a conversion of ectodermal cells into neurons
during embryonic development [14]. In mice, expression
of neurog1 was found to be restricted to the nervous
system. Neurog1 showed high expression levels in
developing sensory but not in autonomic ganglia [14]. In
the central nervous system, neurog1 and neurog2 displayed
overlapping expression patterns and functional redundancy
in various regions of the brain [15]. In the peripheral ner-
vous system, neurog1 and neurog2 displayed specific prop-
erties. Neurog1 and neurog2 were required during different
phases of neurogenesis and for the development of different
classes of sensory neurons [9]. The neurog1 protein was
found to be essential for the development of proximal sen-
sory ganglia and for neurons forming from the trigeminal
and otic placodes [8]. These and other observations in
knock-out mice are in excellent agreement with our clinical
and radiological findings in the patient, which included a
truncation or severe hypoplasia of the vestibulo-cochlear
(VIIIth cranial) nerve. In the neurog1−/− mouse embryos,
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absence of the vestibular-cochlear ganglion and of all affer-
ent, efferent, and autonomic nerve fibers of the VIIIth cra-
nial nerve were reported [10]. The efferent and autonomic
fibers were thought to be lost as a secondary effect due to
the absence of the afferents [10].
Furthermore, the anatomical deviations in the inner
ear of the patient correspond to those in the knockout
mice. The boy’s internal auditory canal was narrowed
and the cochlea was hypoplastic with only one single
widened cochlear turn. In the neurog1−/− mutant mice,
the inner ear showed an overall reduction in size and
the cochlea only had 1.25 turns, as opposed to 1.75
turns in the control littermates [10]. Moreover, the pa-
tient presented with a balance disorder, and the
vestibulo-cochlear system of the neurog1−/− mutant
mice showed a distinct missing utriculosaccular duct
with only a small saccular recess [10].
This patient and the neurog1−/− knockout mice also
shared the severe disorder of oral motor function. The
boy was unable to swallow and to chew food and showed
increased salivation and speech difficulties, while all new-
born neurog1−/− mice were unable to suckle, lacked milk
in their stomachs and died within 12 hours after birth
[10]. Ma et al. suggested that the absence of the trigeminal
ganglia and associated defects of the Vth nerve resulted in
a lack of sensory innervation and neonatal lethality by
interfering with suckling. Correspondingly, we assume a
malfunction of the Vth cranial nerve in the boy that could
be caused by lack of sensory innervation or a missing
motor innervation due to defective development of the
rhombencephalon, which is the origin of the motoric
fibers of the Vth cranial nerve. Taken together, the ana-
tomic and functional abnormalities in mice perfectly
match the symptoms in this patient. Therefore, we
strongly infer that Neurog1 is a neuronal determination
gene for the cranial sensory neurons that give rise to cra-
nial nerves V and VIII in numerous vertebrates including
Xenopus, mouse and humans.
In contrast, we consider TIFAB and DCNP1 unlikely can-
didate genes for the abnormalities in this patient. TIFAB is
highly expressed in spleen and inhibits TIFA-mediated cel-
lular functions by inducing a conformational change in the
TIFA protein [16]. TIFAB impedes activation of NF-kappaB
and acts as a negative regulator of TRAF6-induced cellular
functions such as B cell proliferation and maturation of
macrophages [17]. DCNP1 is a genetic factor that has been
reported to be involved in asthma susceptibility. A case–
control study among subjects with asthma revealed an
association of variants of DCNP1 with serum immuno-
globulin E (IgE) levels [18]. DCNP1 may also play a role in
the pathogenesis of depressive disorders because it was
shown to enhance corticotropin-releasing hormone expres-
sion in the hypothalamic paraventricular nucleus. Hence,DNCP1 interferes with hypothalamic stress response and
may contribute to the pathogenesis of major depression [19].
The clinical findings in our proband perfectly match
with those in patients with CCDD, especially of the
HOXA1 spectrum: among other symptoms, these patients
show severe bilateral sensory-neural hearing loss due to
absence of the cochlear and vestibular apparatus, often ac-
companied by absence of the eighth cranial nerve [1].
Every causative gene characterized in context of CCDDs is
associated with neuronal development at the nuclear,
brainstem, or peripheral nerve level [1,2]. For example,
the responsible gene in Duane Retraction Syndrome
(CHN1) is involved in ocular motor axon path finding of
the sixth nerve. Homozygous mutations in HOXA1 cause
an early and profound brainstem patterning defect and
heterozygous mutations in KIF21A, which are causative
for congenital fibrosis of the extraocular muscles type 1,
lead to disturbance of anterograde organelle transport in
neuronal cells [2].
Taken together, the clinical and molecular genetic findings
in our proband most closely match the term congenital cra-
nial dysinnervation disorder and there are also analogies to
Moebius syndrome and its variants (MIM 157900). In a
large study of Moebius syndrome including 37 Dutch
patients, the following clinical observations are consistent
with those observed in our proband: feeding problems at
birth due to insufficient suckling or swallowing, nasal dys-
arthria and delayed language development, congenital
deafness, motor disabilities, and malformations of the ex-
tremities of variable severity. A lack of sensation of the lips,
cheek, forehead and cornea in some patients indicated a de-
fect of the sensory root of the trigeminal nerve [20]. Other
authors have described external ear deformities, deafness
and pharyngeal involvement in patients with Moebius syn-
drome variants [21-23].
Moreover, the clinical observations made in our pro-
band partially correspond with those described in patients
harboring the homozygous HOXB1 c.619C > T mutation
[24]: the phenotype included bilateral facial palsy, hearing
loss, and strabismus. Two affected brothers from consan-
guineous parents showed a “masked facies” without any
facial movement, sensorineural hearing loss, feeding diffi-
culties and speech delay. MR imaging of the older brother
revealed bilateral absence of the facial nerve and bilateral
cochlear malformation with abnormal tapering of the
basal turn. In contrast to our case, the vestibulocochlear
nerve was preserved on both sides. An affected brother
and sister from another family not known to be consan-
guineous also presented with bilateral facial weakness and
sensorineural hearing loss [24].
The human NEUROG1 maps within the interval of the
DFNB60 locus for non-syndromic autosomal recessive
hearing loss on 5q22-q31, but linkage data have excluded
NEUROG1 from being causative in the DFNB60 patients
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of Otolaryngology - Head and Neck Surgery, University of
Iowa, Iowa City, IA, USA, personal communication). How-
ever, given its large size (35 Mb, >100 genes), the 5q22-q31
area could well harbor more than one deafness gene.
Conclusions
This is the first report on phenotypes associated with
homozygous mutations or deletions of the human
NEUROG1 gene. We find, the clinical findings in this pa-
tient are in excellent coincidence with findings in frog
(Xenopus) and mouse embryos lacking neurog1. The
patient`s parents were phenotypically normal and carried
the deletion in a heterozygous state, indicating autosomal
recessive inheritance. We propose that congenital cranial
dysinnervation disorders involving cranial nerves V and
VIII may be caused by the presence of two null alleles for
the human NEUROG1 gene in a subset of patients. Further
evaluation of the frequency of NEUROG1 mutations in
patients with congenital cranial dysinnervation disorders is
needed before clinical recommendations can be given.
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